FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pulmonology and endocrinology and is intended for early verification if type 2 diabetes mellitus. In the process of type 2 diabetes mellitus diagnostics, chronic obstructive lung disease is estimated as risk factor of type 2 diabetes mellitus and in case of its presence, irrespective of blood sugar indices, obtained on empty stomach, glucose-tolerance test is carried out and by standard criteria disturbance of tolerance to glucose (pre-diabetes) or diabetes is detected.
EFFECT: method allows to increase accuracy of diagnostics of tolerance to glucose and diabetes mellitus, including early stages of development and reduce its terms, therefore reducing economic expenditures on process of diagnostics and treatment.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2740587C1 |
| METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
| PREDICTIVE DIAGNOSTIC TECHNIQUE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2009 |
|
RU2421729C2 |
| DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS METHOD USABLE IN BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE CASES | 2004 |
|
RU2267987C1 |
| METHOD FOR MONITORING INDIVIDUALS WITH RISK OF EARLY ATHEROSCLEROSIS AND SUFFERING FROM TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533836C1 |
| METHOD FOR CORRECTION OF ABDOMINAL TYPE OBESITY AND METABOLIC SYNDROME | 2021 |
|
RU2761727C1 |
| METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
| DIABETES MELLITUS EXPRESS-DIAGNOSTIC METHOD | 2006 |
|
RU2368904C2 |
| METHOD OF TREATING PATIENTS WITH METABOLIC SYNDROME | 2018 |
|
RU2699508C1 |
| METHOD FOR RAPID ASSESSMENT OF RISK OF TYPE 2 DIABETES MELLITUS OR PRE-DIABETES IN INDIVIDUALS OF THE RUSSIAN POPULATION | 2020 |
|
RU2730949C1 |
